About Us

About Us

Afrigen Biologics and Vaccines is a Cape Town based biotechnology company strategically directed, supported and capitalized by Avacare Healthcare Group and the Industrial Development Corporation (IDC) of South Africa.

Announced on 21 June 2021, the objective of the technology transfer hub is to build capacity in low- and middle-income countries to produce mRNA vaccines through a centre of excellence and training (the mRNA vaccine technology hub). The hub is located at Afrigen, Cape Town, South Africa, and will work with a network of technology recipients (spokes) in low- and middle-income countries. 

Through international partnerships and local capacity building, Afrigen has established the first ever adjuvant production and formulation technology  and vaccine facility centre on the African continent.

This centre, in partnership with IDRI, a world leader in adjuvant development, focuses on next generation vaccine adjuvants, which are not only geared at preventing disease, but have therapeutic value.

These adjuvants confer added potency and durability to vaccines. More recently, Afrigen has ventured into the novel CAM’s space where it aims to bring innovative, differentiated products to market.

Collaborators

Affiliations

Afrigen is affiliated with Universities in South Africa. These affiliations help Afrigen extend its reach and allow our scientists to engage within the community. Several of our senior scientists, including Renate Lamprecht, Gerhardt Boukes and Caryn Fenner have appointments at the University of Cape Town, Nelson Mandela University and Northwest University respectively.

Our Team Leaders

  • Mr Mehmet Levent Selamoglu (Chairperson).
  • Prof Petro Terblanche(CEO)
  • Dr Caryn Fenner(mRNA Hub Director)
  • Dr Elize Willenburg(Executive Manager: Formulation Innovation)
  • Mr Rajen Naidoo (Executive Manager: Business Development, IP and Commercial)
  • Ms Helena Heystek (Executive Manager: Functional Support)
  • Dr Johan van Rensburg (Executive Manager: Animal Health)
  • Dr Imelda Jordaan (Executive Manager: Regulatory & Qaulity)
  • Dr Mustaqeem de Gama (Company Secretariat and Head of Legal)
  • Ralph Banks (Responsible Pharmacist)

Our Shareholders